Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 5, 2026
Reporting period
Not applicable
Filed with the SEC
Nov 9, 2026
ChairGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-453834
Filed / recorded
Nov 9, 2026, 10:10 PM UTC
Added to OQRO
Nov 9, 2026, 10:10 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Aspen Neuroscience, Inc.
Issuer CIK
2124080
Ticker
ASPE
Reporting person
Faheem Hasnain
Relationship
Director, Officer
Officer title
Executive Chair
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Nov 5, 2026
Transaction code
A
Shares / units
321,672
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
348,330
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents the number of shares of common stock, which were 100% vested upon grant, to be delivered upon settlement of restricted stock unit award under the Reporting Person's executive chair offer letter on the designated deferred settlement date. The restricted stock units will be settled in one lump sum on the first trading day during calendar year 2027 as of which (A) the lock-up period applicable under the Reporting Person's lock-up agreement with the underwriters of the Issuer's initial public offering has expired or terminated and (B) the Reporting Person is permitted to sell shares of Common Stock in the open market under the Issuer's insider trading policy, but in all cases no later than December 31, 2027.
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.